Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers
NCT01848002
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Congenital Bleeding Disorder
Congenital FXIII Deficiency
Healthy
Interventions
DRUG:
catridecacog
DRUG:
placebo
Sponsor
Novo Nordisk A/S